CSL Bioplasma continues to meet the increasing demand for life-saving, plasma-derived products for Australia and the Asia Pacific region with products manufactured at our facility in Melbourne.

In Australia, plasma-derived products are manufactured from plasma donated by voluntary blood donors, collected by the Australian Red Cross Blood Service (ARCBS) and delivered to CSL Bioplasma for fractionation. CSL has been Australia's national plasma fractionator since 1952.

CSL Bioplasma's continued role as Australia's national fractionator was recently confirmed in a review of Australia's fractionation services. The review arose from Australia-US free trade negotiations and it endorsed the integrity and benefits of Australia's existing system.

CSL Bioplasma's commitment to providing plasma-derived products to treat patients throughout Australia is underpinned by our continuing investment in technology, infrastructure and expertise.

Our products are fractionated using processes compliant with international regulatory standards to ensure high safety and quality. Products are approved for use in Australia by the Therapeutic Goods Administration. As the sponsor for our products on the Australian Therapeutic Goods Register, we also ensure that new and improved products required by clinicians and patients are supported by rigorous research and development data and clinical trials.

We maintain a National Reserve of products to facilitate security of supply. Our finished products are distributed in Australia by the ARCBS. We offer in-field, personalised product support to health care professionals and consumers through our team of product liaison specialists. Along with our product support materials, we provide 24 hour access to medical information and pharmacovigilance services.

Governments and blood services in the Asia Pacific region have had access to CSL Bioplasma's services for many years. Today we also provide plasma fractionation services under contract to the Governments and blood services of New Zealand, Hong Kong, Malaysia, Singapore and Taiwan.

Back | Next